Exact Mass: 367.1396

Exact Mass Matches: 367.1396

Found 176 metabolites which its exact mass value is equals to given mass value 367.1396, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

EMTDB

N-Ethyl-N-methyl-4-(trifluoromethyl)-2-(3,4-dimethoxyphenyl)benzamide

C19H20F3NO3 (367.1395)


   

Casuarine 6-alpha-D-glucoside

3-(hydroxymethyl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydro-1H-pyrrolizine-1,2,7-triol

C14H25NO10 (367.1478)


Casuarine 6-alpha-D-glucoside is found in fruits. Casuarine 6-alpha-D-glucoside is an alkaloid from Eugenia jambolana (jambolan

   

N-Acetyl-6-O-L-fucosyl-D-glucosamine

N-[(2R,3R,4S)-3,4,5-Trihydroxy-1-oxo-6-{[(3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-2-yl]ethanimidate

C14H25NO10 (367.1478)


N-Acetyl-6-O-L-fucosyl-D-glucosamine is an oligosaccharin obtained from human milk (Fiziologiya i Biokhimiya Kulturnykh Rastenii (2002), 34(1), 52-57) [HMDB] N-Acetyl-6-O-L-fucosyl-D-glucosamine is an oligosaccharin obtained from human milk (Fiziologiya i Biokhimiya Kulturnykh Rastenii (2002), 34(1), 52-57).

   

2-Acetamido-2-deoxy-6-O-a-L-fucopyranosyl-D-glucose

N-{3,4,5-trihydroxy-1-oxo-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]hexan-2-yl}ethanimidate

C14H25NO10 (367.1478)


2-Acetamido-2-deoxy-6-O-a-L-fucopyranosyl-D-glucose is an oligosaccharide isolated from the urine of patients with fucosidosis (Fucosidosis is an autosomal recessive lysosomal storage disease caused by defective alpha-L-fucosidase with accumulation of fucose in the tissues. Different phenotypes include clinical features such as neurologic deterioration, growth retardation, visceromegaly, and seizures in a severe early form; coarse facial features, angiokeratoma corporis diffusum, spasticity and delayed psychomotor development in a longer surviving form; and an unusual spondylometaphyseoepiphyseal dysplasia in yet another form. OMIM 230000). (PMID 728478) [HMDB] 2-Acetamido-2-deoxy-6-O-a-L-fucopyranosyl-D-glucose is an oligosaccharide isolated from the urine of patients with fucosidosis (Fucosidosis is an autosomal recessive lysosomal storage disease caused by defective alpha-L-fucosidase with accumulation of fucose in the tissues. Different phenotypes include clinical features such as neurologic deterioration, growth retardation, visceromegaly, and seizures in a severe early form; coarse facial features, angiokeratoma corporis diffusum, spasticity and delayed psychomotor development in a longer surviving form; and an unusual spondylometaphyseoepiphyseal dysplasia in yet another form. OMIM 230000). (PMID 728478).

   

3-O-fucopyranosyl-2-acetamido-2-deoxyglucopyranose

N-[(2R,3R,4R,5R)-4,5,6-Trihydroxy-1-oxo-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-2-yl]ethanimidate

C14H25NO10 (367.1478)


3-O-fucopyranosyl-2-acetamido-2-deoxyglucopyranose is an oligosaccharide is a fucosylated oligosaccharide specific to human, and in milk forms part of the innate immune system. (PMID: 1579031). It is present in a number of proteins, such as human transferrin. Hepatocytes contain a receptor that binds glycoproteins specifically through the fucose in alpha13 linkage to N-acetylglucosamine. (PMID: 276862). It is also present in some forms of human kidney enzyme alpha-L-fucosidase (EC 3.2.1.51) (PMID: 7215135). 3-O-fucopyranosyl-2-acetamido-2-deoxyglucopyranose is an oligosaccharide is a fucosylated oligosaccharide specific to human, and in milk forms part of the innate immune system. (PMID: 1579031)

   

Desmethylazelastine

2-(azepan-4-yl)-4-[(4-chlorophenyl)methyl]-1,2-dihydrophthalazin-1-one

C21H22ClN3O (367.1451)


Desmethylazelastine is a metabolite of Azelastine. Azelastine, an antiallergy and antiasthmatic drug, has been reported to be mainly N-demethylated to desmethylazelastine in humans. Azelastine N-demethylation in humans liver microsomes is catalyzed mainly by CYP3A4 and CYP2D6, and CYP1A2 to a small extent (in average, 76.6, 21.8, and 3.9\\%, respectively. (PMID: 10570018)

   

Corynoline

13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14,16,21-hexaen-12-ol

C21H21NO5 (367.142)


   

Corynoline

(1R,12S,13R)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

C21H21NO5 (367.142)


Corynoline is a benzophenanthridine alkaloid that is chelidonine substituted by a methyl group at position 13. Isolated from the aerial parts of Corydalis incisa, it acts as an acetylcholinesterase inhibitor and also exhibits antineoplastic and hepatoprotective activity. It has a role as a metabolite, an EC 3.1.1.7 (acetylcholinesterase) inhibitor, an antineoplastic agent and a hepatoprotective agent. It is a member of isoquinolines, an organic heterohexacyclic compound, a secondary alcohol, a cyclic acetal and a benzophenanthridine alkaloid. It is functionally related to a chelidonine. Corynoline is a natural product found in Corydalis bungeana, Corydalis remota, and other organisms with data available. A benzophenanthridine alkaloid that is chelidonine substituted by a methyl group at position 13. Isolated from the aerial parts of Corydalis incisa, it acts as an acetylcholinesterase inhibitor and also exhibits antineoplastic and hepatoprotective activity. Corynoline is a reversible and noncompetitive acetylcholinesterase (AChE) inhibitor with an IC50 of 30.6 μM[1]. Corynoline exhibits anti-inflammatory activity by activating Nrf2[2]. Corynoline is a reversible and noncompetitive acetylcholinesterase (AChE) inhibitor with an IC50 of 30.6 μM[1]. Corynoline exhibits anti-inflammatory activity by activating Nrf2[2].

   

Dihydrocurcumin

Dihydrocurcumin

C21H21NO5 (367.142)


   

8-Oxypalmatine

8-Oxypalmatine

C21H21NO5 (367.142)


   
   
   

Lincangenine

Lincangenine

C21H21NO5 (367.142)


   
   

O-Methylsakambullin

O-Methylsakambullin

C18H25NO5S (367.1453)


   

Maybridge3_007620

Maybridge3_007620

C20H21N3O2S (367.1354)


   

CHEMBL1255031

CHEMBL1255031

C21H21NO5 (367.142)


   
   

5b,13-dimethyl-5b,6,7,12b,13,14-hexahydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c][1,3]dioxolo[4,5-i]phenanthridin-6-ol

5b,13-dimethyl-5b,6,7,12b,13,14-hexahydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c][1,3]dioxolo[4,5-i]phenanthridin-6-ol

C21H21NO5 (367.142)


   

1-[4-Hydroxy-6-[2-(dimethylamino)ethyl]benzothiazole-2-yl]-3,4-dihydroisoquinoline-6-ol

1-[4-Hydroxy-6-[2-(dimethylamino)ethyl]benzothiazole-2-yl]-3,4-dihydroisoquinoline-6-ol

C20H21N3O2S (367.1354)


   

beta-D-GlcpNAc-(1-3)-L-Rha

beta-D-GlcpNAc-(1-3)-L-Rha

C14H25NO10 (367.1478)


   
   

(E)-3-(methylsulfonyl)-propenoic acid 4-(3-methyl-2-butenyloxy)-3-methoxyphenethyl amide|O-methylsakambullin

(E)-3-(methylsulfonyl)-propenoic acid 4-(3-methyl-2-butenyloxy)-3-methoxyphenethyl amide|O-methylsakambullin

C18H25NO5S (367.1453)


   

Dehydroocoteine

Dehydroocoteine

C21H21NO5 (367.142)


   

citracridone II

citracridone II

C21H21NO5 (367.142)


   

1,8-dihydroxy-6-(methyl)-3-methoxy-2-(piperidinium-2-yl) anthraquinone

1,8-dihydroxy-6-(methyl)-3-methoxy-2-(piperidinium-2-yl) anthraquinone

C21H21NO5 (367.142)


   

4-Hydroxycapitavine|trihydroxy-5,7,4 (methyl-1 piperidinyl-2)-6 flavone

4-Hydroxycapitavine|trihydroxy-5,7,4 (methyl-1 piperidinyl-2)-6 flavone

C21H21NO5 (367.142)


   
   
   

8-Methoxy-7,8-dihydroberberine

8-Methoxy-7,8-dihydroberberine

C21H21NO5 (367.142)


   

Spiro[isoquinoline-1,2-indene],1,2,3,4,2,3-hexahydro-6,7-dimethoxy-2-methyl-6,7-methylendioxy-1-oxo-

Spiro[isoquinoline-1,2-indene],1,2,3,4,2,3-hexahydro-6,7-dimethoxy-2-methyl-6,7-methylendioxy-1-oxo-

C21H21NO5 (367.142)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Oxypalmatine

2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-8-one

C21H21NO5 (367.142)


8-Oxypalmatine is a natural product found in Berberis actinacantha, Limaciopsis loangensis, and other organisms with data available. Oxypalmatine is isolated from Phellodendron amurense[1].

   

8-OXO-PSEUDOPALMATINE

NCGC00160189-01!8-OXO-PSEUDOPALMATINE

C21H21NO5 (367.142)


   

Demethylazelastine

Demethylazelastine

C21H22ClN3O (367.1451)


   
   
   
   
   
   

N-Acetyl-6-O-L-fucosyl-D-glucosamine

2-(acetylamino)-2-Deoxy-6-O-(6-deoxy-L-galactopyranosyl)-D-glucose

C14H25NO10 (367.1478)


   

2-Acetamido-2-deoxy-6-O-a-L-fucopyranosyl-D-glucose

2-(acetylamino)-2-Deoxy-6-O-(6-deoxy-alpha-L-galactopyranosyl)-delta-glucose

C14H25NO10 (367.1478)


   

-O-Fucopyranosyl-2-acetamido-2-deoxyglucopyranose

2-(acetylamino)-2-Deoxy-3-O-(6-deoxy-alpha-L-galactopyranosyl)- D-glucose

C14H25NO10 (367.1478)


   

Casuarine 6-a-D-glucoside

3-(hydroxymethyl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydro-1H-pyrrolizine-1,2,7-triol

C14H25NO10 (367.1478)


   

N2-ibu-2-OMe-rG

N2-ibu-2-OMe-rG

C15H21N5O6 (367.1492)


N2-Isobutyryl-2'-O-methylguanosine (N2-IBU-2'-OME-RG) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

2-(4-N-FMOC-MORPHOLIN-2-YL)ACETIC ACID

2-(4-N-FMOC-MORPHOLIN-2-YL)ACETIC ACID

C21H21NO5 (367.142)


   

Fmoc-ThpGly-OH

Fmoc-ThpGly-OH

C21H21NO5 (367.142)


   
   

Benzenepropanoic acid,a-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]-, 1,1-dimethylethyl ester,(aS)

Benzenepropanoic acid,a-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]-, 1,1-dimethylethyl ester,(aS)

C21H21NO5 (367.142)


   

N-Fmoc-trans-4-hydroxy-L-proline methyl ester

N-Fmoc-trans-4-hydroxy-L-proline methyl ester

C21H21NO5 (367.142)


   

Boc-L-glutamine p-nitrophenylester

Boc-L-glutamine p-nitrophenylester

C16H21N3O7 (367.1379)


   

4H,6H-Indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium, 5a,10b-dihydro-2-(2,4,6-trimethylphenyl)-, chloride , (5aS,10bR)

4H,6H-Indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium, 5a,10b-dihydro-2-(2,4,6-trimethylphenyl)-, chloride , (5aS,10bR)

C21H22ClN3O (367.1451)


   

4-FMOC-3-CARBOXYMETHYL-MORPHOLINE

4-FMOC-3-CARBOXYMETHYL-MORPHOLINE

C21H21NO5 (367.142)


   

(2R,4S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-hydroxypiperidine-2-carboxylic acid

(2R,4S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-hydroxypiperidine-2-carboxylic acid

C21H21NO5 (367.142)


   

2-ACETAMIDO-2-DEOXY-3-O-(A-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

2-ACETAMIDO-2-DEOXY-3-O-(ALPHA-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

C14H25NO10 (367.1478)


   

(2S)-2-amino-5-(diaminomethylideneamino)-N-(4-methyl-2-oxochromen-7-yl)pentanamide,hydrochloride

(2S)-2-amino-5-(diaminomethylideneamino)-N-(4-methyl-2-oxochromen-7-yl)pentanamide,hydrochloride

C16H22ClN5O3 (367.1411)


   

Benzenepropanoic acid,a-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]-, 1,1-dimethylethyl ester, (aR)-

Benzenepropanoic acid,a-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]-, 1,1-dimethylethyl ester, (aR)-

C21H21NO5 (367.142)


   
   

2-ACETAMIDO-2-DEOXY-6-O-(ALPHA-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

2-ACETAMIDO-2-DEOXY-6-O-(ALPHA-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

C14H25NO10 (367.1478)


   

Edoxaban impurity 6

Edoxaban impurity 6

C16H22ClN5O3 (367.1411)


   

2-Acetamido-2-deoxy-4-O-(a-L-fucopyranosyl)-D-glucopyranose

2-ACETAMIDO-2-DEOX-4-O-(ALPHA-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

C14H25NO10 (367.1478)


   
   

Mirogabalin besylate

Mirogabalin besylate

C18H25NO5S (367.1453)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

(11alpha)-13-Methylchelidonine

(11alpha)-13-Methylchelidonine

C21H21NO5 (367.142)


   

2-(acetylamino)-2-deoxy-3-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-glucopyranose

2-(acetylamino)-2-deoxy-3-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-glucopyranose

C14H25NO10 (367.1478)


   

alpha-L-fucosyl-(1->4)-N-acetyl-beta-D-glucosamine

alpha-L-fucosyl-(1->4)-N-acetyl-beta-D-glucosamine

C14H25NO10 (367.1478)


An amino disaccharide consisting of an alpha-L-fucosyl residue attached to N-acetyl-beta-Dglucosamine by a (1->4)-glycosidic linkage.

   

3-[[(2,3-dimethylanilino)-sulfanylidenemethyl]amino]-1H-indole-2-carboxylic acid ethyl ester

3-[[(2,3-dimethylanilino)-sulfanylidenemethyl]amino]-1H-indole-2-carboxylic acid ethyl ester

C20H21N3O2S (367.1354)


   

N-((2S,3R,4R,5S,6R)-2,4,5-Trihydroxy-6-((((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3-yl)acetamide

N-((2S,3R,4R,5S,6R)-2,4,5-Trihydroxy-6-((((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3-yl)acetamide

C14H25NO10 (367.1478)


   

N-((2R,3R,4R,5S,6R)-2,4,5-Trihydroxy-6-((((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3-yl)acetamide

N-((2R,3R,4R,5S,6R)-2,4,5-Trihydroxy-6-((((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3-yl)acetamide

C14H25NO10 (367.1478)


   

N-((2S,3R,4R,5S,6R)-2,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide

N-((2S,3R,4R,5S,6R)-2,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide

C14H25NO10 (367.1478)


   

4-{(1e)-3-Oxo-3-[(2-Phenylethyl)amino]prop-1-En-1-Yl}-1,2-Phenylene Diacetate

4-{(1e)-3-Oxo-3-[(2-Phenylethyl)amino]prop-1-En-1-Yl}-1,2-Phenylene Diacetate

C21H21NO5 (367.142)


   

2,3,10,11-Tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-8-one

2,3,10,11-Tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-8-one

C21H21NO5 (367.142)


   

(2R)-3-{[1-(5,6-dihydropyridin-2-yl)-2-hydroxy-2-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}ethyl]sulfanyl}-2-acetamidopropanoate

(2R)-3-{[1-(5,6-dihydropyridin-2-yl)-2-hydroxy-2-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}ethyl]sulfanyl}-2-acetamidopropanoate

C17H23N2O5S- (367.1328)


   

3-[(2E,4E)-4,6-dimethylocta-2,4-dienoyl]-1,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-2(1H)-one

3-[(2E,4E)-4,6-dimethylocta-2,4-dienoyl]-1,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-2(1H)-one

C21H21NO5-2 (367.142)


   
   

4-[4-(Benzenesulfonyl)-1-piperazinyl]-2-methylquinoline

4-[4-(Benzenesulfonyl)-1-piperazinyl]-2-methylquinoline

C20H21N3O2S (367.1354)


   

2-[4-[2-(1-Cyclohexenyl)ethylsulfamoyl]-2-methylphenoxy]acetic acid methyl ester

2-[4-[2-(1-Cyclohexenyl)ethylsulfamoyl]-2-methylphenoxy]acetic acid methyl ester

C18H25NO5S (367.1453)


   

1-(4-Morpholinyl)-2-[2-(phenylmethylthio)-1-benzimidazolyl]ethanone

1-(4-Morpholinyl)-2-[2-(phenylmethylthio)-1-benzimidazolyl]ethanone

C20H21N3O2S (367.1354)


   

6-(4-morpholinyl)-3-(2-phenylethyl)-2-sulfanylidene-1H-quinazolin-4-one

6-(4-morpholinyl)-3-(2-phenylethyl)-2-sulfanylidene-1H-quinazolin-4-one

C20H21N3O2S (367.1354)


   

beta-D-GlcpNAc-(1->3)-alpha-L-Fucp

beta-D-GlcpNAc-(1->3)-alpha-L-Fucp

C14H25NO10 (367.1478)


   

N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-2-(6-methoxy-3-benzofuranyl)-N-methylacetamide

N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-2-(6-methoxy-3-benzofuranyl)-N-methylacetamide

C21H21NO5 (367.142)


   

N-[[3-chloro-4-(1-piperidinyl)anilino]-sulfanylidenemethyl]hexanamide

N-[[3-chloro-4-(1-piperidinyl)anilino]-sulfanylidenemethyl]hexanamide

C18H26ClN3OS (367.1485)


   

Fuc(b1-6)b-GlcNAc

Fuc(b1-6)b-GlcNAc

C14H25NO10 (367.1478)


   

4-[3-[[4-(4-fluorophenyl)-1-piperazinyl]-oxomethyl]-2H-isoxazol-5-ylidene]-1-cyclohexa-2,5-dienone

4-[3-[[4-(4-fluorophenyl)-1-piperazinyl]-oxomethyl]-2H-isoxazol-5-ylidene]-1-cyclohexa-2,5-dienone

C20H18FN3O3 (367.1332)


   
   
   
   
   
   
   
   
   
   

alpha-L-Rha-(1->3)-beta-D-GlcNAc

alpha-L-Rha-(1->3)-beta-D-GlcNAc

C14H25NO10 (367.1478)


An amino disaccharide consisting of N-acetyl-beta-D-glucosamine having an alpha-L-rhamnosyl residue attached at the 3-position.

   

beta-L-fucosyl-(1->3)-N-acetyl-beta-D-glucosamine

beta-L-fucosyl-(1->3)-N-acetyl-beta-D-glucosamine

C14H25NO10 (367.1478)


An amino disaccharide consisting of a beta-L-fucosyl residue attached to N-acetyl-beta-Dglucosamine by a (1->3)-glycosidic linkage.

   

4-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-alpha-D-rhamnopyranose

4-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-alpha-D-rhamnopyranose

C14H25NO10 (367.1478)


   

2-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-alpha-L-rhamnopyranose

2-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-alpha-L-rhamnopyranose

C14H25NO10 (367.1478)


   

(1R,5S)-N-(2-chlorophenyl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

(1R,5S)-N-(2-chlorophenyl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C21H22ClN3O (367.1451)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

beta-D-GlcpNAc-(1->3)-alpha-L-Rhap

beta-D-GlcpNAc-(1->3)-alpha-L-Rhap

C14H25NO10 (367.1478)


An amino disaccharide consisting of alpha-L-rhamnose having an N-acetyl beta-D-glucosaminyl residue attached at the 3-position.

   

N-hydroxydebrisoquine O-glucuronide

N-hydroxydebrisoquine O-glucuronide

C16H21N3O7 (367.1379)


   

N-(3-methylbut-2-en-1-yl)-2-sulfanyladenosine

N-(3-methylbut-2-en-1-yl)-2-sulfanyladenosine

C15H21N5O4S (367.1314)


   

Fuc(b1-3)a-GlcNAc

2-ACETAMIDO-2-DEOXY-3-O-(A-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

C14H25NO10 (367.1478)


   

GlcNAc(b1-3)Fuc

GlcNAc(b1-3)Fuc

C14H25NO10 (367.1478)


   

Fuc(b1-6)a-GlcNAc

Fuc(b1-6)a-GlcNAc

C14H25NO10 (367.1478)


   

Fuc(a1-3)a-GlcNAc

Fuc(a1-3)a-GlcNAc

C14H25NO10 (367.1478)


   

GlcNAc(b1-3)b-Fuc

GlcNAc(b1-3)b-Fuc

C14H25NO10 (367.1478)


   

Desmethylazelastine

Desmethylazelastine

C21H22ClN3O (367.1451)


   

3-O-fucopyranosyl-2-acetamido-2-deoxyglucopyranose

3-O-fucopyranosyl-2-acetamido-2-deoxyglucopyranose

C14H25NO10 (367.1478)


   

Casuarine 6-alpha-D-glucoside

Casuarine 6-alpha-D-glucoside

C14H25NO10 (367.1478)


   

beta-D-GlcpNAc-(1->2)-alpha-L-Rhap

beta-D-GlcpNAc-(1->2)-alpha-L-Rhap

C14H25NO10 (367.1478)


An amino disaccharide consisting of alpha-L-rhamnose having an N-acetyl beta-D-glucosaminyl residue attached at the 2-position.

   

beta-D-GlcpNAc-(1->4)-alpha-D-Rhap

beta-D-GlcpNAc-(1->4)-alpha-D-Rhap

C14H25NO10 (367.1478)


An amino disaccharide consisting of an alpha-D-rhamnos residue having an N-acetyl-beta-D-glucosaminyl residue attached at the 4-position.

   

alpha-L-Fucp-(1->3)-D-GlcpNAc

alpha-L-Fucp-(1->3)-D-GlcpNAc

C14H25NO10 (367.1478)


An amino disaccharide consisting of N-acetyl-D-glucosamine having an alpha-L-fucosyl residue attached at the 3-position.

   

alpha-L-fucosyl-(1->3)-N-acetyl-beta-D-glucosamine

alpha-L-fucosyl-(1->3)-N-acetyl-beta-D-glucosamine

C14H25NO10 (367.1478)


An amino disaccharide consisting of an alpha-L-fucosyl residue attached to N-acetyl-beta-Dglucosamine by a (1->3)-glycosidic linkage.

   
   

11-hydroxy-6,7-dimethoxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

11-hydroxy-6,7-dimethoxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

C21H21NO5 (367.142)


   

n-[(2s,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2s,3r,4s,5r,6r)-4,5,6-trihydroxy-2-methyloxan-3-yl]oxy}oxan-3-yl]ethanimidic acid

n-[(2s,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2s,3r,4s,5r,6r)-4,5,6-trihydroxy-2-methyloxan-3-yl]oxy}oxan-3-yl]ethanimidic acid

C14H25NO10 (367.1478)


   

(-)-corycavine

(-)-corycavine

C21H21NO5 (367.142)


   

(+)-14-epicorynoline

NA

C21H21NO5 (367.142)


{"Ingredient_id": "HBIN001452","Ingredient_name": "(+)-14-epicorynoline","Alias": "NA","Ingredient_formula": "C21H21NO5","Ingredient_Smile": "CC12C(CC3=CC4=C(C=C3C1N(CC5=C2C=CC6=C5OCO6)C)OCO4)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6873","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7,16,17-trimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

7,16,17-trimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

C21H21NO5 (367.142)


   

8-{[2-(dimethylamino)ethyl]sulfanyl}-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),4,6,8,10,12,14,16-octaene-6,15-diol

8-{[2-(dimethylamino)ethyl]sulfanyl}-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),4,6,8,10,12,14,16-octaene-6,15-diol

C20H21N3O2S (367.1354)


   

(12s)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

(12s)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

C21H21NO5 (367.142)


   

2-(6-aminopurin-9-yl)-5-({[3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxolan-3-ol

2-(6-aminopurin-9-yl)-5-({[3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxolan-3-ol

C15H21N5O6 (367.1492)


   

13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

C21H21NO5 (367.142)


   

(+/-)-corycavamine

(+/-)-corycavamine

C21H21NO5 (367.142)


   

(2r,3r,5s)-2-(6-aminopurin-9-yl)-5-({[(2r,3r,5s)-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxolan-3-ol

(2r,3r,5s)-2-(6-aminopurin-9-yl)-5-({[(2r,3r,5s)-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxolan-3-ol

C15H21N5O6 (367.1492)


   

(1s,12r,13r)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

(1s,12r,13r)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

C21H21NO5 (367.142)


   

(2s,4e)-4-[(2z)-2-{[(1s)-4-carbamimidamido-1-carboxybutyl]imino}ethylidene]-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

(2s,4e)-4-[(2z)-2-{[(1s)-4-carbamimidamido-1-carboxybutyl]imino}ethylidene]-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

C15H21N5O6 (367.1492)


   

(2r)-2-[4-hydroxy-7-oxo-6-(2-phenylethyl)-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

(2r)-2-[4-hydroxy-7-oxo-6-(2-phenylethyl)-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

C21H21NO5 (367.142)


   

3,4,10,11-tetramethoxy-7,8-dihydro-6-azatetraphen-5-one

3,4,10,11-tetramethoxy-7,8-dihydro-6-azatetraphen-5-one

C21H21NO5 (367.142)


   

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-[(4,5,6-trihydroxy-2-methyloxan-3-yl)oxy]oxan-3-yl]ethanimidic acid

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-[(4,5,6-trihydroxy-2-methyloxan-3-yl)oxy]oxan-3-yl]ethanimidic acid

C14H25NO10 (367.1478)


   

2,3,10,11-tetramethoxy-7,8-dihydro-6-azatetraphen-12-one

2,3,10,11-tetramethoxy-7,8-dihydro-6-azatetraphen-12-one

C21H21NO5 (367.142)


   

(6'r)-6,6'-dimethyl-2',7,8,8'-tetrahydro-2h-spiro[[1,3]dioxolo[4,5-g]isoquinoline-5,7'-indeno[4,5-d][1,3]dioxol]-6'-ol

(6'r)-6,6'-dimethyl-2',7,8,8'-tetrahydro-2h-spiro[[1,3]dioxolo[4,5-g]isoquinoline-5,7'-indeno[4,5-d][1,3]dioxol]-6'-ol

C21H21NO5 (367.142)


   

3-methanesulfonyl-n-(2-{3-methoxy-4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

3-methanesulfonyl-n-(2-{3-methoxy-4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

C18H25NO5S (367.1453)


   

2-[4-hydroxy-7-oxo-6-(2-phenylethyl)-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

2-[4-hydroxy-7-oxo-6-(2-phenylethyl)-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

C21H21NO5 (367.142)


   

(1s,12r,13s)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

(1s,12r,13s)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

C21H21NO5 (367.142)


   

(1r,12r,13r)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

(1r,12r,13r)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

C21H21NO5 (367.142)


   

(2e)-3-methanesulfonyl-n-(2-{3-methoxy-4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

(2e)-3-methanesulfonyl-n-(2-{3-methoxy-4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

C18H25NO5S (367.1453)


   

15,16,17-trimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

15,16,17-trimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

C21H21NO5 (367.142)


   

corycavamine

corycavamine

C21H21NO5 (367.142)


   

8-oxopseudopalmatine

8-oxopseudopalmatine

C21H21NO5 (367.142)


   

8-{[2-(dimethylamino)ethyl]sulfanyl}-6-hydroxy-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),5,7,9,11,13,16-heptaen-15-one

8-{[2-(dimethylamino)ethyl]sulfanyl}-6-hydroxy-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),5,7,9,11,13,16-heptaen-15-one

C20H21N3O2S (367.1354)


   

(1s,12s,13r)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

(1s,12s,13r)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

C21H21NO5 (367.142)